In addition, COVID-19 patients had a lower response to the agonist of NOD2; this innate receptor has been previously reported to recognize viruses through their ssRNA [37], and NLRs and other members of the inflammasomes are activated during severe COVID-19 and in SARS-CoV-2-infected human monocytes [38]. This evidence concerns the gene NOD2 and COVID-19.